Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Change in Account Payables (2016 - 2023)

Rapid Therapeutic Science Laboratories' Change in Account Payables history spans 6 years, with the latest figure at $21258.0 for Q1 2023.

  • For Q1 2023, Change in Account Payables changed N/A year-over-year to $21258.0; the TTM value through Mar 2023 reached $21258.0, changed N/A, while the annual FY2020 figure was -$90000.0, N/A changed from the prior year.
  • Change in Account Payables for Q1 2023 was $21258.0 at Rapid Therapeutic Science Laboratories, down from $90000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $90000.0 in Q1 2020 and bottomed at $1200.0 in Q1 2019.
  • The 3-year median for Change in Account Payables is $21258.0 (2023), against an average of $37960.0.
  • The largest annual shift saw Change in Account Payables tumbled 89.61% in 2019 before it skyrocketed 7400.0% in 2020.
  • A 3-year view of Change in Account Payables shows it stood at $39057.0 in 2019, then surged by 130.43% to $90000.0 in 2020, then crashed by 76.38% to $21258.0 in 2023.
  • Per Business Quant, the three most recent readings for RTSL's Change in Account Payables are $21258.0 (Q1 2023), $90000.0 (Q3 2020), and $18849.0 (Q2 2020).